Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00291) | |||||
---|---|---|---|---|---|
Name |
Folic acid
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
59-30-3; Folate; Pteroylglutamic acid; Vitamin M; Folacin; PteGlu; Folacid; Folvite; Vitamin B9; Vitamin Bc; Folicet; Pteroyl-L-glutamic acid; Acifolic; Cytofol; Folsan; Incafolic; Folettes; Foliamin; Folipac; Millafol; Folbal; Folsav; Pteroyl-L-monoglutamic acid; Mittafol; Pteroylmonoglutamic acid; Antianemia factor; Factor U; Folico (Italy); Folina (Italy); Foldine [France]; Acfol (Spain); Pteroylmonoglutamate; Foldine; Folcysteine; Folasic (Australia); Folcidin; Folsaure; Folaemin [Netherlands]; Vitamin Be; Nifolin [Denmark]; Folcidin (VAN); Kyselina listova [Czech]; Mission prenatal; Novofolacid [Canada]; Acide folique [INN-French]; Acido folico [INN-Spanish]; Acidum folicum [INN-Latin]; Vitamin B11; Liver Lactobacillus casei factor; PGA (VAN); Glutamic acid, pteroyl-, l-; Usaf cb-13; C19H19N7O6; N-pteroyl-L-glutamic acid; Pteroyl-L-glutamate; UNII-935E97BOY8; Kyselina listova; CHEBI:27470; AI3-26387; NSC 3073; 4-Pteridinol, 2-amino-6-((p-((1,3-dicarboxypropyl)carbamoyl)anilino)methyl)-; 59-30-3 (free acid); Glutamic acid, N-(p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-, l-; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; 935E97BOY8; CAS-59-30-3; Novofolacid; Folaemin; Nifolin; Folico; Folina; Acidum folicum; Acido folico; DSSTox_CID_2519; MFCD00079305; Dosfolat B activ; DSSTox_RID_76606; DSSTox_GSID_22519; Folic acid, 96-102%, pure; Folsaeure; Megafol; Neocepri; Acide folique; Pteroyglutamic acid; [3H]folic acid; SMR000471860; CCRIS 666; Folicet (TN); [3H]-folic acid; HSDB 2002; 32108-06-8; EINECS 200-419-0; Preconceive; Folicare; Lexpec; Pteroylglutamate; YEASTFOLATEPOLYGLUTAMATE; Folic acid [BAN:INN:JAN]; NSC-3073; Bio Science; Natur Flow; Pteroyglutamicacid; B03BB01; Folic acid [USP:INN:BAN:JAN]; NCGC00142391-03; Prestwick_230; Folic Acid,(S); Folic Acid USP/BP; Pteroyl-L-monoglutamate; Spectrum_001381; Folic acid, crystalline; Folic acid, USP grade; Folic acid, >=97%; Prestwick3_000627; Spectrum2_001459; Spectrum3_000749; Spectrum4_001751; Spectrum5_000602; bmse000299; SCHEMBL3876; CHEMBL1622; BSPBio_000594; BSPBio_002338; KBioGR_002222; KBioSS_001861; MLS001304016; MLS001335861; MLS002548873; BIDD:ER0563; BIDD:GT0641; DivK1c_000494; SPECTRUM1502020; SPBio_001357; ARONIS014410; BPBio1_000654; Folic acid, analytical standard; GTPL4562; GTPL4563; DTXSID0022519; Folic acid (JP17/USP/INN); SCHEMBL20791897; HMS501I16; KBio1_000494; KBio2_001861; KBio2_004429; KBio2_006997; KBio3_001558; Folic acid, Cell Culture Reagent; NINDS_000494; HMS1921D20; HMS2092N17; HMS2096N16; HMS2270L05; HMS3259A05; HMS3713N16; Pharmakon1600-01502020; ZINC8577218; Tox21_111559; Tox21_300127; BDBM50237629; BDBM50367343; CCG-38869; NSC758158; AKOS000503224; AKOS015895671; AKOS016007919; Tox21_111559_1; DB00158; GS-6860; NC00455; NSC-758158; SDCCGMLS-0066738.P001; IDI1_000494; SMP2_000137; Folic acid, tested according to Ph.Eur.; NCGC00016265-01; NCGC00016265-02; NCGC00016265-03; NCGC00016265-04; NCGC00016265-05; NCGC00016265-08; NCGC00142391-01; NCGC00254203-01; AC-11682; BP-13474; HY-16637; SBI-0051701.P002; Folic acid, meets USP testing specifications; A12227; C00504; D00070; Folic acid, Vetec(TM) reagent grade, >=97%; J10084; Z-4094; 079F305; Q127060; BRD-K18673820-001-07-2; Folic acid, British Pharmacopoeia (BP) Reference Standard; Folic acid, European Pharmacopoeia (EP) Reference Standard; Folic acid, United States Pharmacopeia (USP) Reference Standard; Folic acid, Pharmaceutical Secondary Standard; Certified Reference Material; N-{p-[(2-amino-4-hydroxypteridin-6-yl)methylamino]benzoyl}glutamic acid
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Vitamin deficiency | ICD-11: 5B55 | [1] | ||
PubChem CID | |||||
Formula |
C19H19N7O6
|
||||
Canonical SMILES |
C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
|
||||
InChI |
1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1
|
||||
InChIKey |
OVBPIULPVIDEAO-LBPRGKRZSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=135398658"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 441.4 | Topological Polar Surface Area | 209 | |
XlogP | -1.1 | Complexity | 767 | ||
Heavy Atom Count | 32 | Rotatable Bond Count | 9 | ||
Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 10 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Folic acid 1 mg tablet | Click to Show/Hide the Full List of Formulation(s): 21 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aphena Pharma Solutions-Tennessee; Exelan Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Aidarex Pharmaceuticals; RemedyRepack; West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Blu Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Preferred Pharamaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Apace Packaging; Aphena Pharma Solutions-Tennessee; AvPAK; Cardinal Health; Central Texas Community Health Centers; Clinical Solutions Wholesale; Contract Pharmacal; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Marlex Pharmaceuticals; McKesson; Mylan Pharamceuticals; NCS HealthCare of KY, Inc dba Vangard Labs; NuCare Pharmaceuticals; PD-Rx Pharmaceuticals; Par Pharmaceutical; Physicians Total Care; RemedyRepack; Safecor Health; State of Florida DOH Central Pharmacy; Sunrise Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cadila Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Microcrystalline cellulose; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; American Health Packaging; Cardinal Health; Major Pharmaceuticals; Preferred Pharamaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Breckenridge Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale; Leading Pharma; NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Clinical Solutions Wholesale; Excellium Pharmaceutical; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Microcrystalline cellulose; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Preferred Pharamaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Silicon dioxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Silicon dioxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | State of Florida DOH Central Pharmacy | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 16 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Colloidal silicon dioxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 17 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Colloidal silicon dioxide; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 18 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | McKesson | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 19 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline; Starch, potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Jubilant Cadista Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 20 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AiPing Pharmaceutical; Method Pharmaceuticals; NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 21 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Method Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.